This acquisition enables ESTEVE CDMO (Esteve Química) to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the US. BARCELONA, Spain, July 31, 2025 ESTEVE acquires Regis…
